AHi perspectives: flexible drug labeling and its impact on the drug development process. Liability issues
Thomas, J.W.
Journal of the American Veterinary Medical Association 207(7) 899-900; Discussion: 902-904
1995
ISSN/ISBN: 0003-1488 PMID: 7559021 Document Number: 441573
Document emailed within 1 workday
Related Documents
Apley, M.D. 1995: AHi perspectives: flexible drug labeling and its impact on the drug development process. Practical aspects of flexible labeling in feedlots Journal of the American Veterinary Medical Association 207(7): 901Robinson, D.S. 1994: Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. a pharmaceutical industry perspective on drug labeling Psychopharmacology Bulletin 30(1): 23-25
Koritz, G.D. 1995: American Academy of Veterinary Pharmacology and Therapeutics: perspectives on the utility of flexible drug labeling. An AAVPT perspective: Part I Journal of the American Veterinary Medical Association 207(7): 875-876
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
1993: FDA issues regulations on accelerated drug-approval process Clinical Pharmacy 12(4): 253-254
Boutonnat, J.; Barbier, M.; Ronot, X.; Seigneurin, D. 2000: Nucleus labeling or membrane labeling for studying the proliferation of drug treated cells? Morphologie: Bulletin de l'Association des Anatomistes 84(265): 11-15
Nowotny, O.H. 1978: Trends and perspectives in drug research and development Fortschritte der Medizin 96(12): 615
Fourcroy, J.L. 1998: Issues and priorities in the development of drug treatments for female sexual dysfunction International Journal of Impotence Research 10 Suppl. 2: S121-S123
Volkov, N.M.; Moiseenko, V.M. 2007: Drug therapy for inoperable gastric cancer: current possibilities and perspectives of development Voprosy Onkologii 53(4): 383-392
Whitehouse, P.J.; Sciulli, C.G.; Mason, R.M. 1997: Dementia drug development: use of information systems to harmonize global drug development Psychopharmacology Bulletin 33(1): 129-133
Jordan, S.C.; Choi, J.; Vo, A. 2015: Strategies to Improve Novel Drug Development in Kidney Transplantation Through the Clinical Trials Process Clinical Transplants 31: 163-172
Luna, D.; Otero, C.; Risk, M.; Stanziola, E.; González Bernaldo de Quirós, Fán. 2016: Impact of Participatory Design for Drug-Drug Interaction Alerts. A Comparison Study Between Two Interfaces Studies in Health Technology and Informatics 228: 68-72
Dev, S. 2010: Impact of natural products in modern drug development Indian Journal of Experimental Biology 48(3): 191-198
Kantor, R.; Katzenstein, D. 2003: Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution Aids Reviews 5(1): 25-35
McCulloch, J. 1996: Neuroprotective drug development in stroke: blood pressure and its impact Journal of Hypertension. Supplement: Official Journal of the International Society of Hypertension 14(5): S131-S138
Manuel, J.; Collin-Histed, T. 2013: Orphan drug development and the impact on non-medical support groups Pediatric Endocrinology Reviews: Per 11(Suppl 1): 116-124
Bittner, B.; Mountfield, R.J. 2002: Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters Current Opinion in Drug Discovery and Development 5(1): 59-71
Bergen-Cico, D 2013: Perspectives of U.S. Drug Policy: Observations and Advice From Drug Policy Administrators in Emerging Democracies in Central and Eastern Europe World Medical and Health Policy 5(4): 362-388
Terry, M. 1993: Professional drug labeling Journal of the American Veterinary Medical Association 202(10): 1711-2;discussion 1713-7